[go: up one dir, main page]

KR20010041947A - 결정 형태의 파록세틴 - Google Patents

결정 형태의 파록세틴 Download PDF

Info

Publication number
KR20010041947A
KR20010041947A KR1020007010260A KR20007010260A KR20010041947A KR 20010041947 A KR20010041947 A KR 20010041947A KR 1020007010260 A KR1020007010260 A KR 1020007010260A KR 20007010260 A KR20007010260 A KR 20007010260A KR 20010041947 A KR20010041947 A KR 20010041947A
Authority
KR
South Korea
Prior art keywords
paroxetine
free base
product
crystalline
paroxetine free
Prior art date
Application number
KR1020007010260A
Other languages
English (en)
Korean (ko)
Inventor
앤드류 사이먼 크레이그
닐 워드
윌슨 맥일웨인
Original Assignee
피터 기딩스
스미스클라인비이참피이엘시이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9805581.7A external-priority patent/GB9805581D0/en
Priority claimed from GBGB9813054.5A external-priority patent/GB9813054D0/en
Priority claimed from GBGB9817115.0A external-priority patent/GB9817115D0/en
Application filed by 피터 기딩스, 스미스클라인비이참피이엘시이 filed Critical 피터 기딩스
Publication of KR20010041947A publication Critical patent/KR20010041947A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020007010260A 1998-03-16 1999-03-16 결정 형태의 파록세틴 KR20010041947A (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB9805581.7 1998-03-16
GBGB9805581.7A GB9805581D0 (en) 1998-03-16 1998-03-16 Novel compounds
GBGB9813054.5A GB9813054D0 (en) 1998-06-17 1998-06-17 Novel compounds
GB9813054.5 1998-06-17
GB9817115.0 1998-08-06
GBGB9817115.0A GB9817115D0 (en) 1998-08-06 1998-08-06 Novel compounds
PCT/GB1999/000793 WO1999047519A1 (en) 1998-03-16 1999-03-16 Crystalline form of paroxetine

Publications (1)

Publication Number Publication Date
KR20010041947A true KR20010041947A (ko) 2001-05-25

Family

ID=27269245

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007010260A KR20010041947A (ko) 1998-03-16 1999-03-16 결정 형태의 파록세틴

Country Status (18)

Country Link
EP (1) EP1064282A1 (pt)
JP (1) JP2002506865A (pt)
KR (1) KR20010041947A (pt)
CN (1) CN1300286A (pt)
AP (1) AP2000001907A0 (pt)
AU (1) AU2847199A (pt)
BG (1) BG104839A (pt)
BR (1) BR9908825A (pt)
CA (1) CA2323896A1 (pt)
EA (1) EA200000946A1 (pt)
HU (1) HUP0101215A3 (pt)
ID (1) ID27596A (pt)
IL (1) IL138390A0 (pt)
NO (1) NO20004583L (pt)
PL (1) PL342931A1 (pt)
SK (1) SK13622000A3 (pt)
TR (1) TR200002675T2 (pt)
WO (1) WO1999047519A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9919052D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel compound composition and process
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion

Also Published As

Publication number Publication date
EP1064282A1 (en) 2001-01-03
BG104839A (en) 2001-09-28
HUP0101215A2 (hu) 2002-04-29
TR200002675T2 (tr) 2000-12-21
EA200000946A1 (ru) 2001-02-26
NO20004583D0 (no) 2000-09-14
BR9908825A (pt) 2000-11-21
ID27596A (id) 2001-04-12
CA2323896A1 (en) 1999-09-23
CN1300286A (zh) 2001-06-20
PL342931A1 (en) 2001-07-16
AU2847199A (en) 1999-10-11
NO20004583L (no) 2000-09-15
IL138390A0 (en) 2001-10-31
AP2000001907A0 (en) 2000-09-30
JP2002506865A (ja) 2002-03-05
HUP0101215A3 (en) 2002-05-28
WO1999047519A1 (en) 1999-09-23
SK13622000A3 (sk) 2001-03-12

Similar Documents

Publication Publication Date Title
US5856493A (en) Process for making novel form of paroxeting hydrochloride anhydrate
KR20010013615A (ko) 4-페닐피페리딘 화합물
EP1137636A1 (en) Process for preparation of paroxetine maleate
KR20010041947A (ko) 결정 형태의 파록세틴
CA2164296C (en) Heterocyclic chemistry
JPH09500139A (ja) ヒドロキシルアミンの酸付加塩の合成法
WO2000035910A1 (en) Derivative of paroxetine
RU2177478C2 (ru) Безводная кристаллическая форма гидрохлорида r(-)-n-(4,4-ди (3-метилтиен -2-ил) бут-3-енил)-нипекотиновой кислоты, способ ее получения, фармацевтическая композиция и способ лечения
JPH1143486A (ja) 固体化合物、その調製物及び薬剤における使用
KR20010033317A (ko) 파록세틴 염산염의 제조 방법
DE69014256T2 (de) Benzopyran-Derivate.
MXPA00009137A (es) Forma cristalina de paroxetina
CZ20003343A3 (cs) Krystalická forma paroxetinu
US20020137938A1 (en) Novel process
EP1155016A1 (en) Process for the production of paroxetine hydrochloride acetone solvate
MXPA00006040A (en) Process for the preparation of paroxetine hydrochloride
WO2001025201A1 (en) Process for the preparation of paroxetin intermediate
WO2001012623A1 (en) Process for the preparation of paroxetine hydrochloride
WO2001014369A2 (en) Process for the preparation of paroxetin.hcl
JPH06239835A (ja) アミノケトン誘導体
EP1178962A1 (en) Process for the preparation of paroxetine acetate and analogues thereof
JPH11501953A (ja) 結晶（―）―３ｒ，４ｒ―トランス―７―メトキシ―２，２―ジメチル―３―フェニル―４―｛４―〔２―（ピロリジン―１―イル）エトキシ〕フェニル｝クロマン・酸性フマル酸塩
EP1133492A1 (en) Process for the preparation of paroxetine hydrochloride
WO2000032596A1 (en) Amine salts of paroxetine
JPH11512403A (ja) ２，３，４，５−テトラヒドロ−１ｈ−３−ベンズアゼピン化合物の酸付加塩

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20000916

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid